News at USA Health

The team of faculty, fellows, and medical students from the Department of Neurosurgery gave a total of 10 presentations.

Presented during an event in Birmingham in December, the award was part of the Breast Cancer Research Foundation of Alabama’s $1.125 million investment in state-based research in 2024.

The $10,000 award is presented annually to a promising scientist at the Mitchell Cancer Institute upon the recommendation of a faculty committee.

The North American Skull Base Society is the most prestigious skull base society in the United States and gathers academic research contributions from all over the world.

“The insights gained could also help save more lives in the future and improve outcomes for children experiencing cardiac arrests,” — Mukul Sehgal, M.D., MBA, FAAP

USA Health is one of 18 sites in the nation enrolling patients in the ReInvigorate Study, which will evaluate the safety and efficacy of a new system to increase diaphragm strength and improve ventilation weaning for patients.

"Selection is a testament to our entire team from nursing to physical therapy to advanced practice providers. We are very proud of the level of complex care we are able to provide here, locally, at USA Health, in Mobile, Alabama," said Richard Menger, M.D., MPA.

In this issue, you’ll meet Ocean Kelly, who was born with a rare genetic disorder; hear from leaders in medical education and student affairs at the Whiddon College of Medicine; learn about menopause care available at USA Health; and celebrate with Providence employees as they joined the health system.

Santanu Dasgupta, Ph.D., was awarded $423,500 from the NIMHD, part of the National Institutes of Health, to study mitochondrial DNA mutations in the blood of patients diagnosed with triple-negative breast cancer.

Richard Menger, M.D., MPA, lectured about USA Health’s team-based approach to reducing complications in complex spine deformity care.

Maran Ramani, M.D., was awarded a three-year grant from the Thrasher Research Fund in 2022 to conduct a multinational clinical study, known as the Azithromycin Brain neuroprotection for Children study.

Ovarian cancer ranks fifth in cancer deaths among women, accounting for more deaths than any other gynecologic cancer. Only about 20% of cases are diagnosed at an early stage, when the disease is more treatable.